Head-to-head comparison of stress hyperglycemia ratio versus triglyceride-glucose index for predicting mortality in heart failure: a retrospective cohort study

SHR and TyG index can be used as potential risk assessment tools for short-term (180-, 90-, and 30-day) mortality risk in critically ill HF patients, nevertheless, SHR is a more applicable and robust metabolic biomarker associated with 1-year mortality.